Suppr超能文献

通过等位基因特异性PCR扩增进行HLA - DRB1*01亚型分型:一种灵敏、特异且快速的技术。

HLA-DRB1*01 subtyping by allele-specific PCR amplification: a sensitive, specific and rapid technique.

作者信息

Olerup O, Zetterquist H

机构信息

Center for BioTechnology, Karolinska Institute, NOVUM, Huddinge, Sweden.

出版信息

Tissue Antigens. 1991 May;37(5):197-204. doi: 10.1111/j.1399-0039.1991.tb01872.x.

Abstract

The two DR1-associated cellular specificities Dw1 and Dw20, as well as DR'Br' (Dw'BON'), cannot be unequivocally assigned by serological typing or restriction fragment length polymorphism (RFLP) analysis. We have developed and compared two polymerase chain reaction-based (PCR) typing methods for distinguishing these DRB1 alleles; allele-specific amplification of DRB101 alleles followed by an agarose gel electrophoresis detection step and group-specific DRB101 amplification followed by hybridization with sequence-specific oligonucleotide probes. The two typing strategies gave completely concordant results in the 33 DRB101-positive and the 46 DRB101-negative individuals and cell lines studied. No false-negative or false-positive typing results were obtained. All possible heterozygous combinations of the DRB10101-0103 alleles could be distinguished by both typing methods. DRB101 subtyping by allele-specific PCR amplification was performed in less than 3 hours, including PCR amplification, detection and interpretation steps. The technique will be a valuable complement to DR typing by serology and RFLP analysis. Allele-specific DRB1 amplifications or group-specific amplifications followed by directed allele-specific amplifications of DRB1 alleles, typing based on the absence or presence of amplified products, may well prove to be the technical innovation that will firmly establish PCR-based DR typing in routine clinical tissue typing.

摘要

与DR1相关的两种细胞特异性Dw1和Dw20,以及DR'Br'(Dw'BON'),无法通过血清学分型或限制性片段长度多态性(RFLP)分析明确确定。我们开发并比较了两种基于聚合酶链反应(PCR)的分型方法来区分这些DRB1等位基因;对DRB101等位基因进行等位基因特异性扩增,随后进行琼脂糖凝胶电泳检测步骤,以及对DRB101进行组特异性扩增,随后与序列特异性寡核苷酸探针杂交。在研究的33例DRB101阳性和46例DRB101阴性个体及细胞系中,这两种分型策略给出了完全一致的结果。未获得假阴性或假阳性分型结果。两种分型方法都能区分DRB1*0101 - 0103等位基因的所有可能杂合组合。通过等位基因特异性PCR扩增进行DRB1亚型分型在不到3小时内即可完成,包括PCR扩增、检测和解读步骤。该技术将是血清学和RFLP分析进行DR分型的有价值补充。DRB1等位基因的等位基因特异性扩增或组特异性扩增,随后对DRB1等位基因进行定向等位基因特异性扩增,基于扩增产物的有无进行分型,很可能被证明是一项技术创新,将在常规临床组织分型中牢固确立基于PCR的DR分型。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验